Advance patient safety with the right prescription. First time.
Get the only BNF-integrated clinical decision support system that’s patient specific and locally customisable.
Healthcare professionals should not carry the burden of prescribing errors that are easily mitigated with modern day technologies.
Occur every year in England. 66m thought to be clinically significant.
Occupied every year in England due to medication errors.
Are affected by preventable medication-related harm globally.
Estimated to occur with medication error playing a role every year in England.
Worldwide, estimated by the WHO.
Get the only BNF-integrated clinical decision support system that’s patient specific and locally customisable.
Use Dosium to embed the NICE approved national formulary into your EPMA system.
Use Dosium to advance your EPMA configuration and electronic prescribing systems.
Use Dosium to defend against error-prone steps at scale so you can free up capacity and do more in less time.
Get the only BNF-integrated clinical decision support system that’s quick to access and easy to use.
"Dosium and BNF share a vision for the future of medication safety CDS. Having worked together since 2017, consistent progress has been made possible by our fundamental alignment, harmonised clinical views, as well as substantial allocation of R&D resources by our respective organisations. We are ready to translate that effort into clinical benefit."
"Dosium has the potential to change the way we deliver point-of-prescribing guidance and support. By harnessing the BNF to standardise medication orders, their approach will slash the countless hours spent on local database configurations while advancing functionality and tackling patient safety risks head-on. I can't wait to see the very real benefits this transformation will bring to electronic prescribing."
"Dosium and the BNF share a vision for the future of medication safety CDS. Having worked together since 2017, consistent progress has been made possible by our fundamental alignment, harmonised clinical views, as well as substantial allocation of R&D resources by our respective organisations. We are ready to translate that effort into clinical benefit."
